Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Low Risk of Hypoglycemia : Unlike some other diabetes medications, semaglutide carries a low risk of causing hypoglycemia (low blood sugar), especially when not used with insulin or sulfonylureas
Compounded formulations often cost significantly less than brand-name versions, making longer treatment courses more financially feasible for many patients
Participants were contacted by phone at week 4 to review product compliance, completion of the exercise behavior scale, concomitant therapies, adverse events and study requirements
GLP-1 treatment for diabetes and obesity Semaglutide, a GLP-1 receptor agonist, is the active ingredient in Ozempic for diabetes and in Wegovy for obesity
Gastrointestinal symptoms : Persistent nausea, vomiting, or diarrhoea can lead to dehydration, electrolyte imbalances, and reduced nutrient absorption, all contributing to tiredness
US$ 22.87
US$ 24.12
US$ 29.12
